Back

Inflammatory responses following CRISPR modification of the nuclear localisation sequence in endogenous interleukin-1α

Hoyle, C.; Diaz Pino, R.; Lai, S. M.; Green, J. P.; Adamson, A.; Coutts, G.; Lawrence, C. B.; Travis, M. A.; Lopez-Castejon, G.; Brough, D.

2025-10-01 immunology
10.1101/2025.09.30.679460 bioRxiv
Show abstract

Interleukin (IL)-1 is a pro-inflammatory member of the IL-1 cytokine superfamily and is important for inflammatory responses to infection and injury. Unlike pro-IL-1{beta}, pro-IL-1 is mainly localised to the nucleus upon expression. This is mediated by a nuclear localisation sequence (NLS) responsible for its importin-dependent transport into the nucleus. This nuclear localisation and the presence of histone acetyl transferase (HAT)-binding domains within the pro-domain suggest a role of this cytokine in gene transcription regulation. In addition, nuclear trafficking of pro-IL-1 is proposed to regulate its secretion. To-date, studies on the nuclear role of pro-IL-1 have used overexpression systems. Here, we generated a mouse where the endogenous Il1a gene was edited with CRISPR to disrupt the NLS (mNLS). Using an in vitro approach with murine macrophages we found that this NLS mutation did not affect pro-IL-1 RNA expression levels in response to LPS but increased its protein expression levels. Moreover, we found that the transcriptional signature induced by LPS was not altered between WT and mNLS macrophages. Release of IL-1 in response to different stimuli such as ionomycin was not negatively impacted by disrupted nuclear localisation, although higher levels of IL-1 release were detected, potentially due to increased levels of pro-IL-1. Inflammatory responses in an in vivo model of peritonitis and an influenza infection model were comparable between WT and mNLS mice. Thus, we have established a mouse model in which pro-IL-1 nuclear localisation is disrupted, although future research is required to reveal the importance of this nuclear localisation for IL-1 function.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
Frontiers in Immunology
586 papers in training set
Top 0.1%
23.5%
2
Scientific Reports
3102 papers in training set
Top 5%
10.5%
3
Journal of Leukocyte Biology
40 papers in training set
Top 0.1%
7.5%
4
Life Science Alliance
263 papers in training set
Top 0.1%
7.1%
5
International Journal of Molecular Sciences
453 papers in training set
Top 1.0%
5.1%
50% of probability mass above
6
European Journal of Immunology
57 papers in training set
Top 0.1%
2.8%
7
Molecular Immunology
14 papers in training set
Top 0.1%
2.2%
8
Immunology
29 papers in training set
Top 0.4%
1.8%
9
PLOS ONE
4510 papers in training set
Top 52%
1.7%
10
Frontiers in Genetics
197 papers in training set
Top 5%
1.5%
11
Open Biology
95 papers in training set
Top 0.8%
1.5%
12
The Journal of Immunology
146 papers in training set
Top 1%
1.4%
13
Journal of Cell Science
353 papers in training set
Top 1%
1.4%
14
Brain, Behavior, and Immunity
105 papers in training set
Top 2%
1.3%
15
Biology Open
130 papers in training set
Top 1%
1.3%
16
Immunology & Cell Biology
11 papers in training set
Top 0.1%
1.3%
17
Disease Models & Mechanisms
119 papers in training set
Top 2%
0.9%
18
Frontiers in Physiology
93 papers in training set
Top 5%
0.9%
19
iScience
1063 papers in training set
Top 25%
0.9%
20
EMBO reports
136 papers in training set
Top 5%
0.8%
21
Frontiers in Molecular Biosciences
100 papers in training set
Top 4%
0.8%
22
Cells
232 papers in training set
Top 5%
0.8%
23
eLife
5422 papers in training set
Top 58%
0.7%
24
The FASEB Journal
175 papers in training set
Top 3%
0.7%
25
PLOS Biology
408 papers in training set
Top 20%
0.7%
26
Biomedicines
66 papers in training set
Top 4%
0.7%
27
microLife
19 papers in training set
Top 0.3%
0.7%
28
Biochemical and Biophysical Research Communications
78 papers in training set
Top 2%
0.7%
29
Cell Death & Disease
126 papers in training set
Top 3%
0.5%
30
mBio
750 papers in training set
Top 13%
0.5%